DIAX: Merger On The Table, The Discount To NAV Could Shrink
Source: SeekingAlpha
2025-10-02 08:25:28 ET
Thesis
We have covered the Nuveen Dow 30 Dynamic Overwrite Fund ( DIAX ) several times in the past on the Seeking Alpha platform. The name is a buy-write CEF from Nuveen that has poor structuring and poor long-term results. Our issue with DIAX has always been around its Dow Jones to S&P 500 basis, a structural item that we highlighted in our last article on the website....
Read the full article on Seeking Alpha
For further details see:
DIAX: Merger On The Table, The Discount To NAV Could Shrink
Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest
NASDAQ: DIAX
DIAX Trading
-2.56% G/L:
$14.5477 Last:
22,483 Volume:
$14.61 Open:
DIAX Latest News
March 05, 2026 04:15:00 pm
Nuveen Covered Call Closed-End Funds Announce Shareholder Approval of Proposed Mergers
September 19, 2025 04:15:00 pm
Nuveen Covered Call Closed-End Funds Announce Proposed Mergers and Shareholder Meeting Update
July 24, 2025 05:00:45 am
Will Trump Fire Powell? How to Protect Yourself With a Cheap 8.4% Dividend
